|
[1]
|
In Vitro Bactericidal Activity of a Neomycin-Polymyxin B-Nystatin Combination Compared to Metronidazole and Clindamycin Against the Main Bacteria Involved in Bacterial Vaginosis and Aerobic Vaginitis
Pharmaceuticals,
2025
DOI:10.3390/ph18030340
|
|
|
|
|
[2]
|
Mixed vaginitis. What's new? Features of the course and therapy of mixed vaginitis
Problemy reproduktsii,
2022
DOI:10.17116/repro202228041137
|
|
|
|
|
[3]
|
Difficulties in therapy of aerobic vaginitis and ways to overcome them
Reproductive health of woman,
2021
DOI:10.30841/2708-8731.4.2021.238159
|
|
|
|
|
[4]
|
PRISM study: Comparison of a nystatin-neomycin-polymyxin B combination with miconazole for the empirical treatment of infectious vaginitis
Médecine et Maladies Infectieuses,
2019
DOI:10.1016/j.medmal.2019.01.011
|
|
|
|
|
[5]
|
Prevalence of Bacterial Vaginosis and Its Association with Risk Factors among Nonpregnant Women: A Hospital Based Study
International Journal of Microbiology,
2018
DOI:10.1155/2018/8349601
|
|
|
|
|
[6]
|
A review of international and Russian scientific data on the use of polygynax for the treatment and prevention of patients with nonspecific (aerobic), vulvovaginal candidiasis, and mixed vaginitis
Rossiiskii vestnik akushera-ginekologa,
2018
DOI:10.17116/rosakush201818252-64
|
|
|
|
|
[7]
|
A review of international and Russian scientific data on the use of polygynax for the treatment and prevention of patients with nonspecific (aerobic), vulvovaginal candidiasis, and mixed vaginitis
Rossiiskii vestnik akushera-ginekologa,
2018
DOI:10.17116/rosakush201818252-64
|
|
|
|